Bioequivalence Study of Xian Risperdal Tablets Compared With Gurabo Risperdal Tablets Under Fasting and Fed Conditions in Chinese Healthy Participants
Clinical trial NCT03220867 · WITHDRAWN
Trial details
- NCT number
- NCT03220867
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-11
- Primary completion
- 2018-01-02
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.